CORD-19:e847d433e7424152a9846673209cb73027415ecd / 329676-330081 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T3059","span":{"begin":0,"end":8},"obj":"Sentence"},{"id":"TextSentencer_T3060","span":{"begin":9,"end":405},"obj":"Sentence"},{"id":"T28046","span":{"begin":0,"end":8},"obj":"Sentence"},{"id":"T42324","span":{"begin":9,"end":405},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Methods: Through a cross-sectional study performed on around 1000 HIV-infected patients (p) treated with antiretrovirals at our reference centre, we identified all cases of G related to the administration of at least 12 consecutive months of HAART, to assess possible correlations of G with a spectrum of clinical, laboratory, and therapeutic variables (and including all adverse effects of HAART itself)."}

{"project":"Epistemic_Statements","denotations":[{"id":"T447","span":{"begin":0,"end":405},"obj":"Epistemic_statement"}],"text":"Methods: Through a cross-sectional study performed on around 1000 HIV-infected patients (p) treated with antiretrovirals at our reference centre, we identified all cases of G related to the administration of at least 12 consecutive months of HAART, to assess possible correlations of G with a spectrum of clinical, laboratory, and therapeutic variables (and including all adverse effects of HAART itself)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T349","span":{"begin":0,"end":8},"obj":"Sentence"},{"id":"T350","span":{"begin":9,"end":405},"obj":"Sentence"}],"text":"Methods: Through a cross-sectional study performed on around 1000 HIV-infected patients (p) treated with antiretrovirals at our reference centre, we identified all cases of G related to the administration of at least 12 consecutive months of HAART, to assess possible correlations of G with a spectrum of clinical, laboratory, and therapeutic variables (and including all adverse effects of HAART itself)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1041","span":{"begin":173,"end":174},"obj":"Disease"},{"id":"T1042","span":{"begin":284,"end":285},"obj":"Disease"}],"attributes":[{"id":"A1041","pred":"mondo_id","subj":"T1041","obj":"http://purl.obolibrary.org/obo/MONDO_0001571"},{"id":"A1042","pred":"mondo_id","subj":"T1042","obj":"http://purl.obolibrary.org/obo/MONDO_0001571"}],"text":"Methods: Through a cross-sectional study performed on around 1000 HIV-infected patients (p) treated with antiretrovirals at our reference centre, we identified all cases of G related to the administration of at least 12 consecutive months of HAART, to assess possible correlations of G with a spectrum of clinical, laboratory, and therapeutic variables (and including all adverse effects of HAART itself)."}